| LA | |
|---|---|
| Post | 6.2 |
| Pre | 3.5 |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | 1.2 | 110.2 | 66.5 | - | - | - | 178.0 |
| 1 | - | - | - | - | - | 17.0 | 8.2 | 0.5 | - | - | 25.8 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 46.8 |
| 1 | 7.2 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | - |
| 1 | - |
| Number of post synapses: | 712 |
| Number of pre synapses: | 103 |
| Number of output connections: | 187 |
| Coverage factor: | 1.2 |
| Columnar completeness: | 0.15 |
| Area completeness: | 0.20 |
| Cell size (columns): | 29 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#Lat3 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe17a (R) | Glu | 158 | 39.5 | 15.0% | 15.0% |
| 1 | MeVP45 (R) | ACh | 94 | 23.5 | 9.0% | 24.0% |
| 2 | Lat3 (R) | unclear | 76 | 19.0 | 7.2% | 31.2% |
| 3 | MeVC3 (L) | ACh | 73 | 18.2 | 7.0% | 38.2% |
| 4 | Cm34 (R) | Glu | 62 | 15.5 | 5.9% | 44.1% |
| 5 | aMe12 (R) | ACh | 58 | 14.5 | 5.5% | 49.6% |
| 6 | aMe26 (R) | ACh | 40 | 10.0 | 3.8% | 53.4% |
| 7 | Cm31b (R) | GABA | 36 | 9.0 | 3.4% | 56.9% |
| 8 | aMe2 (R) | Glu | 32 | 8.0 | 3.0% | 59.9% |
| 9 | Mi10 (R) | ACh | 32 | 8.0 | 3.0% | 63.0% |
| 10 | MeVP1 (R) | ACh | 30 | 7.5 | 2.9% | 65.8% |
| 11 | MeVC20 (R) | Glu | 21 | 5.2 | 2.0% | 67.8% |
| 12 | 5thsLNv_LNd6 (R) | ACh | 17 | 4.2 | 1.6% | 69.4% |
| 13 | aMe22 (R) | Glu | 17 | 4.2 | 1.6% | 71.0% |
| 14 | CL125 (R) | unclear | 17 | 4.2 | 1.6% | 72.7% |
| 15 | aMe17b (R) | GABA | 16 | 4.0 | 1.5% | 74.2% |
| 16 | Cm1 (R) | ACh | 15 | 3.8 | 1.4% | 75.6% |
| 17 | Cm5 (R) | GABA | 14 | 3.5 | 1.3% | 77.0% |
| 18 | Cm20 (R) | GABA | 12 | 3.0 | 1.1% | 78.1% |
| 19 | Mi15 (R) | ACh | 12 | 3.0 | 1.1% | 79.2% |
| 20 | Dm2 (R) | ACh | 11 | 2.8 | 1.0% | 80.3% |
| 21 | Cm8 (R) | GABA | 10 | 2.5 | 1.0% | 81.2% |
| 22 | MeTu1 (R) | ACh | 10 | 2.5 | 1.0% | 82.2% |
| 23 | Cm24 (R) | Glu | 9 | 2.2 | 0.9% | 83.0% |
| 24 | Lat1 (R) | unclear | 9 | 2.2 | 0.9% | 83.9% |
| 25 | Cm3 (R) | GABA | 8 | 2.0 | 0.8% | 84.7% |
| 26 | MeVC27 (L) | unclear | 7 | 1.8 | 0.7% | 85.3% |
| 27 | Tm29 (R) | Glu | 7 | 1.8 | 0.7% | 86.0% |
| 28 | aMe4 (R) | ACh | 6 | 1.5 | 0.6% | 86.6% |
| 29 | aMe12 (L) | ACh | 5 | 1.2 | 0.5% | 87.0% |
| 30 | Cm17 (R) | GABA | 5 | 1.2 | 0.5% | 87.5% |
| 31 | Cm31a (R) | GABA | 5 | 1.2 | 0.5% | 88.0% |
| 32 | DNpe053 (R) | ACh | 5 | 1.2 | 0.5% | 88.5% |
| 33 | MeTu3c (R) | ACh | 5 | 1.2 | 0.5% | 89.0% |
| 34 | OA-AL2i4 (R) | OA | 5 | 1.2 | 0.5% | 89.4% |
| 35 | aMe1 (R) | GABA | 4 | 1.0 | 0.4% | 89.8% |
| 36 | aMe5 (R) | ACh | 4 | 1.0 | 0.4% | 90.2% |
| 37 | Cm6 (R) | GABA | 4 | 1.0 | 0.4% | 90.6% |
| 38 | Dm9 (R) | Glu | 4 | 1.0 | 0.4% | 91.0% |
| 39 | OA-AL2i3 (R) | OA | 4 | 1.0 | 0.4% | 91.3% |
| instance | NT | total connections | connections /#Lat3 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Lat3 (R) | unclear | 76 | 19.0 | 21.4% | 21.4% |
| 1 | Cm9 (R) | Glu | 17 | 4.2 | 4.8% | 26.2% |
| 2 | Cm35 (R) | GABA | 12 | 3.0 | 3.4% | 29.6% |
| 3 | Cm34 (R) | Glu | 11 | 2.8 | 3.1% | 32.7% |
| 4 | R1-R6 (R) | His | 11 | 2.8 | 3.1% | 35.8% |
| 5 | aMe10 (R) | ACh | 10 | 2.5 | 2.8% | 38.6% |
| 6 | Cm11c (R) | ACh | 10 | 2.5 | 2.8% | 41.4% |
| 7 | aMe15 (R) | unclear | 8 | 2.0 | 2.3% | 43.7% |
| 8 | aMe4 (R) | ACh | 8 | 2.0 | 2.3% | 45.9% |
| 9 | MeVP59 (R) | ACh | 7 | 1.8 | 2.0% | 47.9% |
| 10 | aMe26 (R) | ACh | 6 | 1.5 | 1.7% | 49.6% |
| 11 | Cm20 (R) | GABA | 6 | 1.5 | 1.7% | 51.3% |
| 12 | L1 (R) | Glu | 6 | 1.5 | 1.7% | 53.0% |
| 13 | Cm10 (R) | GABA | 5 | 1.2 | 1.4% | 54.4% |
| 14 | Cm14 (R) | GABA | 5 | 1.2 | 1.4% | 55.8% |
| 15 | Cm3 (R) | GABA | 5 | 1.2 | 1.4% | 57.2% |
| 16 | MeTu1 (R) | ACh | 5 | 1.2 | 1.4% | 58.6% |
| 17 | MeVP45 (R) | ACh | 5 | 1.2 | 1.4% | 60.0% |
| 18 | Dm2 (R) | ACh | 4 | 1.0 | 1.1% | 61.1% |
| 19 | MeLo6 (R) | ACh | 4 | 1.0 | 1.1% | 62.3% |
| 20 | MeTu3b (R) | ACh | 4 | 1.0 | 1.1% | 63.4% |
| 21 | MeVP9 (R) | ACh | 4 | 1.0 | 1.1% | 64.5% |
| 22 | MeVPMe5 (L) | Glu | 4 | 1.0 | 1.1% | 65.6% |
| 23 | Tm5c (R) | Glu | 4 | 1.0 | 1.1% | 66.8% |